Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Lower frequency of insulin pump treatment in children and adolescents of Turkish background with type 1 diabetes: analysis of 21,497 patients in Germany.

Icks A, Razum O, Rosenbauer J, Bächle C, Hungele A, Mönkemöller K, Müller-Godeffroy E, Heidtmann B, Kapellen T, Scheuing N, Holl RW.

Diabetes Technol Ther. 2012 Dec;14(12):1105-9. doi: 10.1089/dia.2012.0138.

2.

Race, socioeconomic status, and treatment center are associated with insulin pump therapy in youth in the first year following diagnosis of type 1 diabetes.

Lin MH, Connor CG, Ruedy KJ, Beck RW, Kollman C, Buckingham B, Redondo MJ, Schatz D, Haro H, Lee JM, Tamborlane WV, Wood JR; Pediatric Diabetes Consortium..

Diabetes Technol Ther. 2013 Nov;15(11):929-34. doi: 10.1089/dia.2013.0132. Epub 2013 Jul 19.

3.

Discontinuation of insulin pump treatment in children, adolescents, and young adults. A multicenter analysis based on the DPV database in Germany and Austria.

Hofer SE, Heidtmann B, Raile K, Fröhlich-Reiterer E, Lilienthal E, Berghaeuser MA, Holl RW; DPV-Science-Initiative and the German working group for insulin pump treatment in pediatric patients..

Pediatr Diabetes. 2010 Mar;11(2):116-21. doi: 10.1111/j.1399-5448.2009.00546.x. Epub 2009 Jun 29.

PMID:
19566740
4.

Impact of Maternal Country of Birth on Type-1-Diabetes Therapy and Outcome in 27,643 Children and Adolescents from the DPV Registry.

Scheuing N, Wiegand S, Bächle C, Fröhlich-Reiterer E, Hahn E, Icks A, Ludwig KH, Mönkemöller K, Razum O, Rosenbauer J, Holl RW; DPV initiative..

PLoS One. 2015 Aug 21;10(8):e0135178. doi: 10.1371/journal.pone.0135178. eCollection 2015.

5.

Type II diabetes mellitus and impaired glucose regulation in Caucasian children and adolescents with obesity living in Germany.

Wabitsch M, Hauner H, Hertrampf M, Muche R, Hay B, Mayer H, Kratzer W, Debatin KM, Heinze E.

Int J Obes Relat Metab Disord. 2004 Feb;28(2):307-13.

PMID:
14724655
6.

Improved metabolic control in children and adolescents with type 1 diabetes: a trend analysis using prospective multicenter data from Germany and Austria.

Rosenbauer J, Dost A, Karges B, Hungele A, Stahl A, Bächle C, Gerstl EM, Kastendieck C, Hofer SE, Holl RW; DPV Initiative and the German BMBF Competence Network Diabetes Mellitus..

Diabetes Care. 2012 Jan;35(1):80-6. doi: 10.2337/dc11-0993. Epub 2011 Nov 10.

7.
8.

Continuous glucose monitoring in children with type 1 diabetes: before and after insulin pump therapy.

Heptulla RA, Allen HF, Gross TM, Reiter EO.

Pediatr Diabetes. 2004 Mar;5(1):10-5.

PMID:
15043684
9.

Risk factors for discontinuation of insulin pump therapy in pediatric and young adult patients.

Kostev K, Rockel T, Rosenbauer J, Rathmann W.

Prim Care Diabetes. 2014 Dec;8(4):346-51. doi: 10.1016/j.pcd.2014.03.006. Epub 2014 Apr 13.

PMID:
24735947
10.

Improved glycemic control after long-term insulin pump use in pediatric patients with type 1 diabetes.

Scrimgeour L, Cobry E, McFann K, Burdick P, Weimer C, Slover R, Chase HP.

Diabetes Technol Ther. 2007 Oct;9(5):421-8.

PMID:
17931050
11.

Factors associated with increased risk of insulin pump discontinuation in pediatric patients with type 1 diabetes.

de Vries L, Grushka Y, Lebenthal Y, Shalitin S, Phillip M.

Pediatr Diabetes. 2011 Aug;12(5):506-12. doi: 10.1111/j.1399-5448.2010.00701.x. Epub 2010 Aug 15.

PMID:
20723097
12.
14.
15.

Insulin pump use in Europe.

Renard E.

Diabetes Technol Ther. 2010 Jun;12 Suppl 1:S29-32. doi: 10.1089/dia.2009.0189.

PMID:
20515303
16.

Costs of paediatric diabetes care in Germany: current situation and comparison with the year 2000.

Bächle CC, Holl RW, Straßburger K, Molz E, Chernyak N, Beyer P, Schimmel U, Rütschle H, Seidel J, Lepler R, Holder M, Rosenbauer J, Icks A; DPV Initiative.; German BMBF Competence Network Diabetes Mellitus..

Diabet Med. 2012 Oct;29(10):1327-34. doi: 10.1111/j.1464-5491.2012.03645.x.

PMID:
22417295
17.

Direct diabetes-related costs in young patients with early-onset, long-lasting type 1 diabetes.

Bächle C, Icks A, Straßburger K, Flechtner-Mors M, Hungele A, Beyer P, Placzek K, Hermann U, Schumacher A, Freff M, Stahl-Pehe A, Holl RW, Rosenbauer J; DPV Initiative and the German BMBF Competence Network Diabetes Mellitus..

PLoS One. 2013 Aug 13;8(8):e70567. doi: 10.1371/journal.pone.0070567. eCollection 2013.

18.

Weight in adolescents with type 1 diabetes mellitus during continuous subcutaneous insulin infusion (CSII) therapy.

Raile K, Noelle V, Landgraf R, Schwarz HP.

J Pediatr Endocrinol Metab. 2002 May;15(5):607-12.

PMID:
12014519
19.

High prevalence of depressive symptoms in well-controlled adolescents with type 1 diabetes treated with continuous subcutaneous insulin infusion.

Zduńczyk B, Sendela J, Szypowska A.

Diabetes Metab Res Rev. 2014 May;30(4):333-8. doi: 10.1002/dmrr.2499.

PMID:
24323887
20.

Factors associated with glycemic control in adult type 1 diabetes patients treated with insulin pump therapy.

Matejko B, Skupien J, Mrozińska S, Grzanka M, Cyganek K, Kiec-Wilk B, Malecki MT, Klupa T.

Endocrine. 2015 Feb;48(1):164-9. doi: 10.1007/s12020-014-0274-2. Epub 2014 May 6.

PMID:
24798448

Supplemental Content

Support Center